Potentiation of apoptosis by flavopiridol in mitomycin-C-treated gastric and breast cancer cells

Clinical Cancer Research

Volumn 3, Issue 9, 1997, Pages 1467-1472

  Schwartz, Gary K ^a,b   Farsi, Kian ^b   Maslak, Peter ^b   Kelsen, David P ^a   Spriggs, David ^b  

^a Division of Solid Tumor Oncology   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLAVONE DERIVATIVE; FLAVOPIRIDOL; L 86 8275; MITOMYCIN C; PROTEIN KINASE C; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; DRUG POTENTIATION; ETIOLOGY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; STOMACH CANCER;

ANTIBIOTICS, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS; APOPTOSIS; BREAST NEOPLASMS; CELL CYCLE; DNA FRAGMENTATION; DRUG ADMINISTRATION SCHEDULE; DRUG SCREENING ASSAYS, ANTITUMOR; DRUG SYNERGISM; FEMALE; FLAVONOIDS; HUMANS; MITOMYCIN; PIPERIDINES; STIMULATION, CHEMICAL; STOMACH NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0030824869     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Senderowicz, A. M., Headlee, D., Stinson, S., Lush, R. M., Figg, W. D., Pluda, J., and Sausville, E. A Phase I trial of a novel cyclic-dependent kinase inhibitor flavopiridol in patients with refractory neoplasms. Proc. Am. Soc. Clin. Oncol., 16: 226a, 1997.
2. Maik, R. G., Kattice, S. L., Bhat, S. V., Alreja, B., De Souza, N. J., and Rupp, R. H. An anti-inflammatory cum immunomodulatory piperidinylhenzopyranone from Dysoxylum binectariferum: isolation, structure and total synthesis. Tetrahedron, 44: 2081-2086, 1988.
3. Kaur, G., Stelter-Stevenson, M., Sebers, S., Worland, P., Sedlacek, H., Myers, C., Czech, J., Naik, R., and Sausville, E. Growth inhibition with reversible cell cycle arrest of carcinoma cells by flavone L86-8275. J. Natl. Cancer Inst., 84: 1736-1740, 1992.
4. Parker, B. W., Senderowicz, A. M., Nieves-Neira, W., Pommier, Y., and Sausville, E. A. DNA fragmentation and apoptosis of lymphoma and prostate cancer cell lines after flavopiridol treatment. Proc. Am. Assoc. Cancer Res., 37: 398, 1996.
5. Drees, M., Dengle, W. A., Roth, T., Labonte, H., May, J., Malspeis, L., Grever, M., Sausville, E. A., and Fiebig, H. H. Flavopiridol (L86-8275): selective antitumor activity in vitro and activity in vivo for prostate carcinoma cells. Clin. Cancer Res., 3: 273-279, 1997.
6. Bible, K. C., and Kaufmann, S. H. Flavopiridol. A cytotoxic flavone that induces cell death in noncycling A549 human luna carcinoma cells. Cancer Res., 56: 4856-4861, 1996.
7. Losiewicz, M. D., Carlson, B. A., Kaur, G., Sausville, E. A., and Worland, P. J. Potent inhibition of cdc2 kinase activity by the flavonoid L86-8275. Biochem. Biophys. Res. Commun., 201: 589-595, 1994.
8. 1 arrest with inhibition of cyclin-dependent kinase (CDK) 2 and CDK4 in human breast carcinoma cells. Cancer Res., 56: 2973-2978, 1996.
9. Worland, P. J., Kaur, G., and Stetler-Stevenson, M. Alteration of the phosphorylation state or p34cdc2 kinase by the flavone L86-8275 in breast carcinoma cells. Biochem. Pharmacol., 46: 1831-1840, 1993.
10. Jarvis, W. D., Fornari, F. A., Browning, J. L., Gerwitz, D. A., Kolesnick, R. N., and Grant, S. Attenuation of ceramide-induced apoptosis by diglyceride in human myeloid leukemia cells. J. Biol. Chem., 268: 31685-31692, 1994.
11. Obeid, L. M., Linardic, C. M., Karolak, L. A., and Hannun, Y. A. Programmed cell death induced by ceramide. Science (Washington DC), 259: 1769-1771, 1993.
12. Jarvis, W. D., Turner, A. J., Povirk, L. F., Taylor, R. S., and Grant, S. Induction of apoptotic DNA fragmentation and cell death in HL-60 human promyelocytic leukemia cells by pharmacological inhibitors of protein kinase C. Cancer Res., 54: 1707-1714, 1994.
13. Haimovitz-Friedman, A., Chu-Cheng, K., Ehleiter, D., and Persaud, R. S. Ionizing radiation acts on cellular membranes to generate ceramide and initiate apoptosis. J. Exp. Med., 180: 525-535, 1994.
14. Lucas, M., and Sanchez-Margalet, V. Protein kinase C involvement in apoptosis. Gen. Pharmacol., 26: 881-887, 1995.
15. Schwartz, G. K., Haimovitz-Friedman, A., Dhupar, S. K., Ehleiter, D., Maslak, P., Lai, L., Laganzo, L., Kelsen, D. P., Fuks, Z., and Albino, A. P. Potentiation of apoptosis by treatment with the protein kinase C specific inhibitor safingol in mitomycin-C treated gastric cancer cells. J. Natl. Cancer Inst., 87: 1394-1399, 1995.
16. Kaufmann, S. H., Desnoyers, S., Ottaviano, Y., Davidson, N., and Poirier, G. G. Specific proteolytic fragmentation of poly(ADP-ribose) polymerase. An early marker of chemotherapy-induced apoptosis. Cancer Res., 53: 3976-3985, 1993.
17. Li, X., James, W., Traganos, F., and Darzynkiewicz, Z. Application of biotin, digoxigenin, or fluorescein conjugated deoxynucleotides to label DNA strand breaks for analysis of cell proliferation and apoptosis using flow cytometry. Biotech. Histochem., 70(5): 234-241, 1995.
18. Danso, D., Farsi, K., Greaney, C., Spriggs, D., Kelsen, D. K., and Schwartz, G. K. The protein kinase C (PKC) inhibitor safingol (SAF) restores Mitomycin-C (MMC)-induced loss of PKCα and PKCε expression in association with the induction of apoptosis. Proc. Am. Assoc. Cancer Res., 38: 194, 1997.
19. Yin, D. X., and Shimke, R. T. Bcl-2 expression delays drug-induced apoptosis but does not increase clonogenic survival after drug treatment in HeLa cells. Cancer Res., 55: 4922-4928, 1995.
20. Wylie, A. H., Kerr, J. F. R., and Currie, A. R. Cell death: the significance of apoptosis. Int. Rev. Cytol., 68: 251-306, 1990.
21. Nabeya, Y., Loganzo, F., Maslak, P., Lai, L., DeOliveira, A., Schwanz, G. K., Blundell, M. L., Altorki, N. K., Kelsen, D. P., and Albino, A. P. The mutational status of p53 protein in gastric and esophageal adenocarcinorna cell lines predicts sensitivity to chemotherapeutic agents. Int. J. Cancer Predict. Oncol., 64: 1-10, 1995.
22. Bartek, J., Iggo, R., Gannon, J., and Lane, D. P. Genetic and immunochemical analysis of mutant p53 in human breast cancer cells lines. Oncogene, 5: 893-899, 1990.
23. Werner, J. L., Greaney, C., Spriggs, D., Kelsen, D. K., and Schwartz, G. K. The enhancement of chemotherapy-induced apoptosis by flavopiridol (flavo) in gastric cancer cells is sequence dependent. Proc. Am. Soc. Clin. Oncol., 16: 547a, 1997.